Skip to Content

Bioqual Inc BIOQ

Morningstar Rating
$64.00 +5.00 (8.47%)
View Full Chart
Unlock Our Analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

BIOQ is trading at a 49% discount.
Price
$64.36
Fair Value
$614.44
Uncertainty
Extreme
1-Star Price
$5,388.95
5-Star Price
$5.92
Economic Moat
Vdyh
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BIOQ is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$59.00
Day Range
$63.0064.00
52-Week Range
$59.00104.00
Bid/Ask
$51.00 / $200.00
Market Cap
$57.34 Mil
Volume/Avg
200 / 595

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield
0.78%
Dividend Yield (Forward)
0.78%
Total Yield
0.78%

Company Profile

Bioqual Inc is a United States-based medical research company. It is engaged in providing contract research services focused on animal models of human diseases, including AIDS, influenza, RSV infection, flavivirus infections like Zika and Dengue, malaria, hepatitis, and cancer. The company is also involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. It provides services to the federal government, universities, and the life science and pharmaceutical industries. It derives revenue from the provision of contract research services.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Small Growth
Total Number of Employees
117

Valuation

Metric
BIOQ
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
BIOQ

Financial Strength

Metric
BIOQ
Quick Ratio
3.75
Current Ratio
4.14
Interest Coverage
107.19
Quick Ratio
BIOQ

Profitability

Metric
BIOQ
Return on Assets (Normalized)
14.91%
Return on Equity (Normalized)
17.85%
Return on Invested Capital (Normalized)
17.51%
Return on Assets
BIOQ

Diagnostics & Research Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
TMO
Thermo Fisher Scientific IncFqtls$191.7 Bil
DHR
Danaher CorpRfdpwd$165.1 Bil
IDXX
IDEXX Laboratories IncFmmttj$40.1 Bil
IQV
IQVIA Holdings IncBcmlgks$39.6 Bil
A
Agilent Technologies IncYmgx$37.6 Bil
MTD
Mettler-Toledo International IncZxjfgk$23.9 Bil
ICLR
Icon PLCNhxwry$22.2 Bil
LH
Laboratory Corp of America HoldingsGsnnyyl$18.6 Bil
ILMN
Illumina IncWnsphm$17.4 Bil
WAT
Waters CorpPkcp$17.1 Bil